Thrombin inhibitors based on a propargylglycine template

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 7, 1999, Pages 1013-1018

  Lee, Koo ^a   Hwang, Sang Yeul ^a   Park, Cheol Won ^a  

^a LG Chemical Ltd   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

1 [3 (4 AMIDINOPHENYL) 2 (1,2,3,4 TETRAHYDRO 2 METHYL 7 ISOQUINOLINYLSULFONAMIDO)PROPIONYL] 1,2,3,6 TETRAHYDRO 4 METHYLPICOLINIC ACID; ARGATROBAN; BENZAMIDINE; GLYCINE DERIVATIVE; GUANIDINE DERIVATIVE; LB 30057; PHENYLENEDIAMINE; PROPARGYLGLYCINE; SERINE PROTEINASE; THROMBIN; THROMBIN INHIBITOR; TRYPSIN; UNCLASSIFIED DRUG;

ARTICLE; DRUG BIOAVAILABILITY; DRUG POTENCY; DRUG SYNTHESIS; ORAL DRUG ADMINISTRATION; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

ALKYNES; ANIMALS; ANTITHROMBINS; AREA UNDER CURVE; GLYCINE; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033526120     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00125-0     Document Type: Article

References (32)

1. 1. For reviews, see: (a) Ripka, W. C. Curr. Opin. Chem. Biol. 1997, 1, 242.
2. (b) Lee, K. J. Kor. Med. Chem. 1997, 6, 127.
3. (c) Edmunds, J. J.; Rapundalo, S. T. Annu. Rep. Med. Chem. 1996, 31, 51.
4. (d) Stone, S. R. Trends Cardiovasc. Med. 1995, 5, 134.
5. (e) Das, J; Kimball, S. D. Bioorg. Med. Chem. 1995, 3, 999.
6. (f) Kimball, S. D. Blood Coagulation and Fibrinolysis, 1995, 6, 511.
7. (g) Tapparelli, C.; Metternich, R.; Ehrhardty, C.; Cook, N. S. Trends Pharm. Sci. 1993, 366.
8. 2. Bush, L. R. Card. Drug Rev. 1991, 9, 247. This drug was discovered by Mitsubishi/Daiichi and has been available in Japan since 1990 for the treatment of peripheral vascular disease. Its Phase III clinical trials in the U.S. and Canada have been completed by Texas Biotechnology.
9. 3. (a) Kim, I.-C.; Oh, Y. S.; Yun, M.; Hwang, S. Y.; Hong, S.; Lee, Y. H.; Lee, K.; Kim, S.; Yoo, Y. J.; Yoon, K. H.; Kim, D. S.; Lee, C. H. Circulation 1997, 96, I-41.
10. (b) Oh, Y. S.; Yun, M.; Hwang, S. Y.; Hong, S.; Shin, Y.; Lee, K.; Yoon, K. H.; Yoo, Y. J.; Kim, D. S.; Lee, S. H.; Lee, Y. H.; Park. H. D.; Lee, C. H.; Lee, S. K.; Kim, S. Bioorg. Med. Chem. Lett. 1998, 8, 631.
11. 4. (a) Danilewitcz, J. C. et al. International Patent Application WO 9513274, 1995.
12. (b) Allen, M.; Abel, S. M.; Barber, C. G.; Cussans, N. J.; Danilewicz, J. C.; Ellis, D.; Hawkeswood, E.; Herron, M.; Holland, S.; Fox, D. N. A.; James, K.; Kobylecki, R. J.; Overington, J. P.; Pandit, J.; Parmar, H.; Powling, M. J.; Ranee, D. J.; Taylor, W.; Shepperson, N. B. 215th ACS National Meeting 1998, Dallas, TX, Abstract MEDI 64.
13. 5. (a) Kim, S.; Hong, C. Y.; Lee, K.; Lee, E. J.; Koh, J. S. Bioorg. Med. Chem. Lett. 1998, 8, 735.
14. (b) Kim, S.; Hong, C. Y.; Koh, J. S.; Lee, E. J.; Lee, K. Molecular Diversity 1998, 3, 133.
15. 6. (a) Lumma Jr., W. C.; Witherup, K. M.; Tucker, T. J.; Brady, S. F.; Sisko, J. T.; Naylor-Olsen, A. M.; Lewis, S. D.; Lucas, B. J.; Vacca, J. P. J. Med. Chem. 1998, 41, 1011.
16. (b) Tucker, T. J.; Lumma, W. C.; Lewis, S. D.; Gardel, S. J.; Lucas, B. J.; Sisko, J. T.; Lynch, J. J.; Lyle, E. A.; Baskin, E. P.; Woltmann, R.; Appleby, S. D.; Chen, I-W.; Dancheck, K. B.; Naylor-Olsen, A. M.; Krueger, J. A.; Cooper, C. M.; Vacca, J. P. J. Med. Chem. 1997, 40, 3687.
17. (c) Misra, R. N.; Kelly, Y. F.; Brown, R. R.; Roberts, D. G. M.; Chong, S.; Seiler, S. Bioorg. Med. Chem. 1994, 4, 2165.
18. (d) Angliker, H.; Wilstrom, P.; Shaw, E. Biochem. J. 1990, 266, 829.
19. 7. Feng, D.-M.; Gardell, S. J.; Lewis, S. D.; Bock, M. G.; Chen, Z.; Freidinger, R. M.; Naylor-Olsen, A. M.; Ramjit, H. G.; Woltmann, R.; Baskin, E. P.; Lynch, J. J.; Lucas, R; Shafer, J. A.; Chen, I-W.; Dancheck, K. B.; Mao, S.-S.; Krueger, J. A.; Hare, T. R; Mulichak, A. M.; Vacca, J. P. J. Med. Chem. 1997, 40, 3726.
20. 8. Details of this data will be described in a later publication.
21. 9. (a) Lee, K.; Hwang, S. Y.; Hong, S. W.; Hong, C. Y.; Lee, C.-S.; Shin, Y.; Kim, S.; Yoo, Y. J.; Kang, M.; Oh, Y. S. Bioorg. Med. Chem. 1998, 6, 869.
22. (b) Lee, K.; Hwang, S. Y.; Yun, M.; Kim, D. S. Bioorg. Med. Chem. Lett. 1998, 8, 1683.
23. (c) Lee, K.; Jung, W.-H.; Park, C. W.; Hong, C. Y.; Kim, I. C.; Kim, S.; Oh, Y. S.; Kwon, O. H.; Lee, S.-H.; Park, H. D.; Kim, S. W.; Lee, Y. H.; Yoo, Y. J. Bioorg. Med. Chem. Lett. 1998, 8, 2563.
24. 10. (a) Baldwin, J. E.; Bradley, M.; Abbot, S. D.; Adlington, R. M. Tetrahedron 1991, 47, 5309.
25. (b) Leukart, O.; Caviezel, M.; Eberle, A.; Escher, E.; Tun-Kyi, A.; Schwyzer, R. Helv. Chim. Acta. 1976, 59, 2181.
26. (c) Gershon, H.; Shapira, J.; Meek, J. S.; Dittmer, K. J. Am. Chem. Soc. 1954, 76, 3484.
27. 11. In the saponification/decarboxylation step (step b), use of one equivalent of base was found be effective for both high yield and high reproducibility.
28. 9a
29. 13. Crisp, G. T.; Roberston, T. A. Tetrahedron 1992, 48, 3239.
30. 14. Sy, W.-W. Synth. Commun. 1992, 22, 3215.
31. 15. Examples: N-trityl-4-iodoimidazole (6), 2-amino-5-bromopyridine (7), N-Boc-2-amino-5-bromothiazole (8), N-Boc-4-iodoaniline (11), 2-nitro-4-iodoaniline (12), N-methyl-2-amino-5-bromopyridine (15), N-Boc-4-bromobenzylamine (19).
32. 16. Details of experimental protocols are described in ref 9c.